AAAAAA

   
Results: 1-24 |
Results: 24
PILOT EVALUATION OF VENLAFAXINE HYDROCHLORIDE FOR THE THERAPY OF HOT FLASHES IN CANCER SURVIVORS
Authors: LOPRINZI CL PISANSKY TM FONSECA R SLOAN JA ZAHASKY KM QUELLA SK NOVOTNY PJ RUMMANS TA DUMESIC DA PEREZ EA
Citation: Cl. Loprinzi et al., PILOT EVALUATION OF VENLAFAXINE HYDROCHLORIDE FOR THE THERAPY OF HOT FLASHES IN CANCER SURVIVORS, Journal of clinical oncology, 16(7), 1998, pp. 2377-2381
RADIATION-THERAPY FOR RECTOSIGMOID AND RECTAL-CANCER - RESULTS OF THE1992-1994 PATTERNS OF CARE PROCESS SURVEY
Authors: MINSKY BD COIA L HALLER DG HOFFMAN J JOHN M LANDRY J PISANSKY TM WILLETT C MAHON I OWEN J BERKEY B KATZ A HANKS G
Citation: Bd. Minsky et al., RADIATION-THERAPY FOR RECTOSIGMOID AND RECTAL-CANCER - RESULTS OF THE1992-1994 PATTERNS OF CARE PROCESS SURVEY, Journal of clinical oncology, 16(7), 1998, pp. 2542-2547
TREATMENT SYSTEMS GUIDELINES FOR PRIMARY RECTAL-CANCER FROM THE 1996 PATTERNS OF CARE STUDY
Authors: MINSKY BD COIA L HALLER D HOFFMAN J JOHN M LANDRY J PISANSKY TM WILLETT C MAHON I OWEN J HANKS G
Citation: Bd. Minsky et al., TREATMENT SYSTEMS GUIDELINES FOR PRIMARY RECTAL-CANCER FROM THE 1996 PATTERNS OF CARE STUDY, International journal of radiation oncology, biology, physics, 41(1), 1998, pp. 21-27
PREDICTORS OF SURVIVAL FOR PROSTATE CARCINOMA PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY AFTER RADIATION-THERAPY
Authors: CHENG L SEBO TJ SLEZAK J PISANSKY TM BERGSTRALH EJ NEUMANN RM ICZKOWSKI KA ZINCKE H BOSTWICK DG
Citation: L. Cheng et al., PREDICTORS OF SURVIVAL FOR PROSTATE CARCINOMA PATIENTS TREATED WITH SALVAGE RADICAL PROSTATECTOMY AFTER RADIATION-THERAPY, Cancer, 83(10), 1998, pp. 2164-2171
NONPALPABLE, PROSTATE-SPECIFIC ANTIGEN DETECTED PROSTATIC-CARCINOMA -DISEASE OUTCOME AFTER IRRADIATION OR RADICAL PROSTATECTOMY
Authors: HADDOCK MG KOZELSKY TF PISANSKY TM
Citation: Mg. Haddock et al., NONPALPABLE, PROSTATE-SPECIFIC ANTIGEN DETECTED PROSTATIC-CARCINOMA -DISEASE OUTCOME AFTER IRRADIATION OR RADICAL PROSTATECTOMY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 216-216
CONFORMAL EXTERNAL-BEAM TREATMENT OF PROSTATE-CANCER - EDITORIAL COMMENT
Authors: PISANSKY TM
Citation: Tm. Pisansky, CONFORMAL EXTERNAL-BEAM TREATMENT OF PROSTATE-CANCER - EDITORIAL COMMENT, Urology, 50(1), 1997, pp. 92-92
IRRADIATION FOR LOCALLY RECURRENT CARCINOMA OF THE PROSTATE FOLLOWINGRADICAL PROSTATECTOMY
Authors: VANDERKOOY MJ PISANSKY TM CHA SS BLUTE ML
Citation: Mj. Vanderkooy et al., IRRADIATION FOR LOCALLY RECURRENT CARCINOMA OF THE PROSTATE FOLLOWINGRADICAL PROSTATECTOMY, Urology, 49(1), 1997, pp. 65-70
ACCELERATED HYPERFRACTIONATION RADIATION-THERAPY AFTER LUMPECTOMY ANDAXILLARY LYMPH-NODE DISSECTION IN PATIENTS WITH STAGE-I OR STAGE-II BREAST-CANCER - PILOT-STUDY
Authors: SCHOMBERG PJ SHANAHAN TG INGLE JN DONOHUE JH KUSKE RR STERNFELD WC WOLD L CHA SS PETERSEN IA BRINDLE JS HALYARD MY BOLLINGER JW HAWKINS R PISANSKY TM
Citation: Pj. Schomberg et al., ACCELERATED HYPERFRACTIONATION RADIATION-THERAPY AFTER LUMPECTOMY ANDAXILLARY LYMPH-NODE DISSECTION IN PATIENTS WITH STAGE-I OR STAGE-II BREAST-CANCER - PILOT-STUDY, Radiology, 202(2), 1997, pp. 565-569
CURRENT PROGNOSTIC FACTORS - RENAL-CELL CARCINOMA - WORKGROUP NO 4
Authors: SRIGLEY JR HUTTER RVP GELB AB HENSON DE KENNEY G KING BF RAZIUDDIN S PISANSKY TM
Citation: Jr. Srigley et al., CURRENT PROGNOSTIC FACTORS - RENAL-CELL CARCINOMA - WORKGROUP NO 4, Cancer, 80(5), 1997, pp. 994-996
AN ENHANCED PROGNOSTIC SYSTEM FOR CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE (VOL 79, PG 2154, 1997)
Authors: PISANSKY TM KAHN MJ BOSTWICK DG
Citation: Tm. Pisansky et al., AN ENHANCED PROGNOSTIC SYSTEM FOR CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE (VOL 79, PG 2154, 1997), Cancer, 80(2), 1997, pp. 350-350
A MULTIPLE PROGNOSTIC INDEX PREDICTIVE OF DISEASE OUTCOME AFTER IRRADIATION FOR CLINICALLY LOCALIZED PROSTATE CARCINOMA
Authors: PISANSKY TM KAHN MJ RASP GM CHA SS HADDOCK MG BOSTWICK DG
Citation: Tm. Pisansky et al., A MULTIPLE PROGNOSTIC INDEX PREDICTIVE OF DISEASE OUTCOME AFTER IRRADIATION FOR CLINICALLY LOCALIZED PROSTATE CARCINOMA, Cancer, 79(2), 1997, pp. 337-344
AN ENHANCED PROGNOSTIC SYSTEM FOR CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE
Authors: PISANSKY TM KAHN MJ BOSTWICK DG
Citation: Tm. Pisansky et al., AN ENHANCED PROGNOSTIC SYSTEM FOR CLINICALLY LOCALIZED CARCINOMA OF THE PROSTATE, Cancer, 79(11), 1997, pp. 2154-2161
NEOADJUVANT CHEMOTHERAPY PLUS CONCURRENT CHEMOTHERAPY AND HIGH-DOSE RADIATION FOR SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A PRELIMINARY-ANALYSIS OF THE PHASE-II INTERGROUP TRIAL 0122
Authors: MINSKY BD NEUBERG D KELSEN DP PISANSKY TM GINSBERG R BENSON A
Citation: Bd. Minsky et al., NEOADJUVANT CHEMOTHERAPY PLUS CONCURRENT CHEMOTHERAPY AND HIGH-DOSE RADIATION FOR SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A PRELIMINARY-ANALYSIS OF THE PHASE-II INTERGROUP TRIAL 0122, Journal of clinical oncology, 14(1), 1996, pp. 149-155
CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH SEMINAL-VESICLE INVASION IN RADICAL PROSTATECTOMY SPECIMENS
Authors: PISANSKY TM BLUTE ML SUMAN VJ BOSTWICK DG EARLE JD ZINCKE H
Citation: Tm. Pisansky et al., CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH SEMINAL-VESICLE INVASION IN RADICAL PROSTATECTOMY SPECIMENS, International journal of radiation oncology, biology, physics, 36(3), 1996, pp. 585-591
CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH HISTOLOGIC FINDING FROM PELVIC LYMPHADENECTOMY SPECIMENS (VOL 34, PG 33, 1996)
Authors: PISANSKY TM ZINCKE H SUMAN VJ BOSTWICK DG EARLE JD OESTERLING JE
Citation: Tm. Pisansky et al., CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH HISTOLOGIC FINDING FROM PELVIC LYMPHADENECTOMY SPECIMENS (VOL 34, PG 33, 1996), International journal of radiation oncology, biology, physics, 35(1), 1996, pp. 203-203
CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH HISTOLOGIC-FINDINGS FROM PELVIC LYMPHADENECTOMY SPECIMENS
Authors: PISANSKY TM ZINCKE H SUMAN VJ BOSTWICK DG EARLE JD OESTERLING JE
Citation: Tm. Pisansky et al., CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH HISTOLOGIC-FINDINGS FROM PELVIC LYMPHADENECTOMY SPECIMENS, International journal of radiation oncology, biology, physics, 34(1), 1996, pp. 33-39
CONSERVATIVE THERAPY OF BREAST-CANCER - THE MAYO-CLINIC EXPERIENCE
Authors: HALYARD MY GRADO GL SCHOMBERG PJ WEAVER AL GRANT CS PISANSKY TM
Citation: My. Halyard et al., CONSERVATIVE THERAPY OF BREAST-CANCER - THE MAYO-CLINIC EXPERIENCE, American journal of clinical oncology, 19(5), 1996, pp. 445-450
WORKGROUP-5 - ASSESSMENT OF PROSTATE CARCINOMA IN-CORE NEEDLE-BIOPSY - DEFINITION OF MINIMAL CRITERIA FOR THE DIAGNOSIS OF CANCER IN BIOPSYMATERIAL
Authors: ALGABA F EPSTEIN JI ALDAPE HC FARROW GM LOPEZBELTRAN A MAKSEM J OROZCO RE PACELLI A PISANSKY TM TRIAS I
Citation: F. Algaba et al., WORKGROUP-5 - ASSESSMENT OF PROSTATE CARCINOMA IN-CORE NEEDLE-BIOPSY - DEFINITION OF MINIMAL CRITERIA FOR THE DIAGNOSIS OF CANCER IN BIOPSYMATERIAL, Cancer, 78(2), 1996, pp. 376-381
A PILOT EVALUATION OF ALTERNATING PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH LOCOREGIONALLY ADVANCED BREAST-CARCINOMA
Authors: PISANSKY TM LOPRINZI CL CHA SS FITZGIBBONS RJ GRANT CS HASS AC REUTER NF WOLD LE INGLE JN KARDINAL CG
Citation: Tm. Pisansky et al., A PILOT EVALUATION OF ALTERNATING PREOPERATIVE CHEMOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH LOCOREGIONALLY ADVANCED BREAST-CARCINOMA, Cancer, 77(12), 1996, pp. 2520-2528
PROGNOSTIC FACTORS FOR PATIENTS WITH CARCINOMA OF THE BREAST
Authors: WOLD LE INGLE JN PISANSKY TM JOHNSON RE DONOHUE JH
Citation: Le. Wold et al., PROGNOSTIC FACTORS FOR PATIENTS WITH CARCINOMA OF THE BREAST, Mayo Clinic proceedings, 70(7), 1995, pp. 678-679
BREAST-CONSERVATION THERAPY FOR INVASIVE BREAST-CANCER - A REVIEW OF PRIOR TRIALS AND THE MAYO-CLINIC EXPERIENCE
Authors: PISANSKY TM HALYARD MY WEAVER AL DONOHUE JH GRADO GL GRANT CS HARTMANN LC INGLE JN SCHOMBERG PJ WOLD LE
Citation: Tm. Pisansky et al., BREAST-CONSERVATION THERAPY FOR INVASIVE BREAST-CANCER - A REVIEW OF PRIOR TRIALS AND THE MAYO-CLINIC EXPERIENCE, Mayo Clinic proceedings, 69(6), 1994, pp. 515-524
PROSTATE-SPECIFIC ANTIGEN AS A PRETHERAPY PROGNOSTIC FACTOR IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
Authors: PISANSKY TM CHA SS EARLE JD DURR ED KOZELSKY TF WIEAND HS OESTERLING JE
Citation: Tm. Pisansky et al., PROSTATE-SPECIFIC ANTIGEN AS A PRETHERAPY PROGNOSTIC FACTOR IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER, Journal of clinical oncology, 11(11), 1993, pp. 2158-2166
DOSES TO RADIATION-SENSITIVE ORGANS AND STRUCTURES LOCATED OUTSIDE THE RADIOTHERAPEUTIC TARGET VOLUME FOR 4 TREATMENT SITUATIONS
Authors: FOO ML MCCULLOUGH EC FOOTE RL PISANSKY TM SHAW EG
Citation: Ml. Foo et al., DOSES TO RADIATION-SENSITIVE ORGANS AND STRUCTURES LOCATED OUTSIDE THE RADIOTHERAPEUTIC TARGET VOLUME FOR 4 TREATMENT SITUATIONS, International journal of radiation oncology, biology, physics, 27(2), 1993, pp. 403-417
PATTERNS OF TUMOR RELAPSE FOLLOWING MASTECTOMY AND ADJUVANT SYSTEMIC THERAPY IN PATIENTS WITH AXILLARY LYMPH NODE-POSITIVE BREAST-CANCER - IMPACT OF CLINICAL, HISTOPATHOLOGIC, AND FLOW CYTOMETRIC FACTORS
Authors: PISANSKY TM INGLE JN SCHAID DJ HASS AC KROOK JE DONOHUE JH WITZIG TE WOLD LE
Citation: Tm. Pisansky et al., PATTERNS OF TUMOR RELAPSE FOLLOWING MASTECTOMY AND ADJUVANT SYSTEMIC THERAPY IN PATIENTS WITH AXILLARY LYMPH NODE-POSITIVE BREAST-CANCER - IMPACT OF CLINICAL, HISTOPATHOLOGIC, AND FLOW CYTOMETRIC FACTORS, Cancer, 72(4), 1993, pp. 1247-1260
Risultati: 1-24 |